We are live on
!
Find out more
Westfield Capital Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
49.45%
This Fund
S&P 500
This Quarter
Est. Return
+7.74%
1 Year Est. Return
+49.45%
3 Year Est. Return
+148.08%
5 Year Est. Return
+180.9%
10 Year Est. Return
+972.69%
AUM
$13B
AUM Growth
+$372M
(+3%)
Cap. Flow
-$235M
Cap. Flow
% of AUM
-1.81%
Top 10 Holdings %
Top 10 Hldgs %
21.21%
Holding
261
New
31
Increased
110
Reduced
68
Closed
35
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$170M |
| 2 |
Marvell Technology
MRVL
|
+$63M |
| 3 |
Avery Dennison
AVY
|
+$58.8M |
| 4 |
Sun Communities
SUI
|
+$56.5M |
| 5 |
Genpact
G
|
+$56.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$107M |
| 2 |
GTM
ZoomInfo Technologies
GTM
|
+$86.1M |
| 3 |
Meta Platforms (Facebook)
META
|
+$65.6M |
| 4 |
Microchip Technology
MCHP
|
+$64.9M |
| 5 |
Gartner
IT
|
+$64.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.49% |
| 2 | Healthcare | 20.94% |
| 3 | Industrials | 14.76% |
| 4 | Consumer Discretionary | 14.52% |
| 5 | Financials | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RXDX
126
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $35M | 0.27% |
+318,174
| New | +$20.6M |
|
127
RingCentral
RNG
$5.28B
| $34.5M | 0.27% |
+974,224
| New | +$34.8M |
|
|
KRTX
128
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $34.4M | 0.27% |
+174,946
| New | +$37.5M |
|
129
Repligen
RGEN
$9.25B
| $34M | 0.26% |
200,870
+34,622
| +21% | +$6.28M |
|
130
Independence Realty Trust
IRT
$4.07B
| $33.3M | 0.26% |
1,977,901
-18,669
| -0.9% | -$316K |
|
|
AAT
131
American Assets Trust
AAT
$1.4B
| $33.1M | 0.26% |
1,248,082
+43,386
| +4% | +$1.17M |
|
|
PDCE
132
DELISTED
PDC Energy, Inc.
PDCE
| $32.6M | 0.25% |
513,090
-159,983
| -24% | -$11.2M |
|
133
Neurocrine Biosciences
NBIX
$16.6B
| $32.6M | 0.25% |
272,688
-187,495
| -41% | -$22M |
|
|
PAYA
134
DELISTED
Paya Holdings Inc. Class A Common Stock
PAYA
| $32.2M | 0.25% |
4,086,331
-901,152
| -18% | -$6.95M |
|
135
Entegris
ENTG
$23.2B
| $32.1M | 0.25% |
+490,106
| New | +$36.1M |
|
136
FTI Consulting
FCN
$4.18B
| $32M | 0.25% |
201,413
+2,632
| +1% | +$439K |
|
137
Cable One
CABO
$212M
| $31.8M | 0.25% |
+44,621
| New | +$33.3M |
|
138
Samsara
IOT
$23.8B
| $31.7M | 0.24% |
2,551,001
+12,859
| +0.5% | +$146K |
|
139
MaxLinear
MXL
$6.8B
| $31.6M | 0.24% |
929,997
-836,204
| -47% | -$28.3M |
|
140
Northern Oil and Gas
NOG
$2.35B
| $31M | 0.24% |
1,005,339
+38,517
| +4% | +$1.3M |
|
141
Zscaler
ZS
$27.3B
| $30.3M | 0.23% |
270,876
-120,469
| -31% | -$16.4M |
|
142
BILL Holdings
BILL
$4.78B
| $30.2M | 0.23% |
276,997
+29,257
| +12% | +$3.51M |
|
|
EDR
143
DELISTED
Endeavor Group Holdings, Inc.
EDR
| $29.3M | 0.23% |
1,301,410
-17,998
| -1% | -$384K |
|
144
Dynatrace
DT
$14.2B
| $29M | 0.22% |
+757,424
| New | +$27.5M |
|
|
AMED
145
DELISTED
Amedisys
AMED
| $27.5M | 0.21% |
329,605
+12,430
| +4% | +$1.12M |
|
|
NEX
146
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $27.2M | 0.21% |
2,942,181
+118,989
| +4% | +$1.16M |
|
147
Azenta
AZTA
$1.48B
| $26.8M | 0.21% |
460,478
+95,354
| +26% | +$4.88M |
|
148
Axalta
AXTA
$8.17B
| $26.7M | 0.21% |
1,048,168
+40,067
| +4% | +$990K |
|
149
Primerica
PRI
$9.89B
| $25.7M | 0.2% |
180,934
+8,057
| +5% | +$1.12M |
|
150
Haemonetics
HAE
$4B
| $25.4M | 0.2% |
323,558
+12,188
| +4% | +$980K |
|
Similar funds
OAG
JG
CHP
SC
Westfield Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, Westfield Capital Management held 261 positions worth $13B, up 3% from $12.6B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Westfield Capital Management's Q4 2022 filing shows 31 new, 110 increased, 68 reduced and 35 closed positions. Its largest new stake was Bank of America: 1,498,651 shares worth $49.6M. The largest sale was Humana, an estimated $107M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 28% a quarter earlier, followed by Healthcare and Industrials.
- Westfield Capital Management's largest Q4 2022 buy was Bank of America: 1,498,651 shares worth $49.6M.
- Westfield Capital Management added most to UnitedHealth in Q4 2022, an estimated $170M increase.
- Westfield Capital Management's biggest Q4 2022 reduction was Microchip Technology, cutting an estimated $64.9M.
- Westfield Capital Management fully exited Humana in Q4 2022, selling an estimated $107M.
- Westfield Capital Management's ten largest holdings make up 21% of its $13B portfolio in Q4 2022.
- Westfield Capital Management opened 31 new positions and closed 35 in Q4 2022.
- Westfield Capital Management's portfolio value rose 3% quarter-over-quarter to $13B.
Based on Westfield Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.